SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Momenta Pharmaceuticals Inc.
MNTA 52.480.0%Oct 2 5:00 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
From: tom pope3/26/2011 4:31:21 PM
  Read Replies (1) of 3027
 
From the oracle -

Cramer said that Momenta Pharmaceuticals (MNTA_) has its fate in the hands of TEVA Pharmaceuticals (TEVA_), as that company is also seeking approval to compete with one of Momenta's drugs. Cramer called Momenta an event-drive stock that's too speculative.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext